Related Experiment Videos
Modeling choice behavior for new pharmaceutical products.
M F Bingham1, F R Johnson, D Miller
1Triangle Economic Research, Durham, NC, USA. mfb@ter.com
Summary
This study introduces a dynamic model for predicting pharmaceutical product adoption using patient learning and preference data. It enhances marketing strategies by incorporating shifting preferences and market share dynamics.
Area of Science:
- Health Economics
- Pharmaceutical Marketing
- Behavioral Economics
Background:
- Traditional marketing models often fail to capture the dynamic nature of pharmaceutical markets.
- Patient learning and evolving preferences significantly influence drug selection and market share.
- Stated-preference data offers insights but has limitations in pharmaceutical applications.
Purpose of the Study:
- To present a dynamic generalization of a marketing model for pharmaceutical products.
- To predict adoption rates for new pharmaceutical products using a random-utility framework.
- To incorporate patient learning and shifting preferences into market share predictions.
Main Methods:
- Utilized stated-preference data within a random-utility framework.
- Employed a Markov model to simulate patient learning in drug selection.
- Integrated random-utility theory with product attribute updating.
Main Results:
- The model systematically incorporates learning and shifting preferences, influencing market share.
- Demonstrated the capability to accommodate various pharmaceutical marketing and development challenges.
- Highlighted both the strengths and limitations of stated-preference research in this context.
Conclusions:
- The dynamic model provides a robust framework for pharmaceutical marketing and development decisions.
- Patient learning and preference dynamics are crucial factors in predicting new drug adoption.
- Further research is needed to refine the model and address stated-preference data limitations.